Leukemia, a form of blood cancer characterized by the abnormal proliferation of white blood cells, presents significant challenges in both diagnosis and treatment. Early detection is critical to improving patient outcomes, yet traditional diagnostic methods, such as complete blood counts (CBCs), microscopic blood smear examinations, and bone marrow biopsies, have limitations. While effective, these methods can be invasive and require considerable clinical expertise, particularly for detecting leukemia in its earliest stages. Recent advancements in artificial intelligence (AI) are revolutionizing leukemia diagnostics by enhancing accuracy, speed, and accessibility. AI algorithms facilitate the rapid analysis of large datasets, automating cell classification and enabling earlier detection. These technologies not only complement traditional methods but also offer more efficient and precise diagnostic capabilities, potentially reducing the reliance on invasive procedures. This paper explores how AI is transforming leukemia diagnostics, providing a more refined approach that supports earlier detection and personalized treatment strategies, ultimately improving patient care and outcomes.